Mini Quiz: Schizophrenia Research

Author(s):

Current trials are investigating adjunctive monoclonal antibody immunotherapy in schizophrenia. Take the quiz and learn more.

Current trials are investigating adjunctive monoclonal antibody immunotherapy in schizophrenia with all of the following agents EXCEPT:

A. Adalimumab

B. Canakinumab

C. Siltuximab

D. Tocilizumab

E. Natalizumab

Receive trusted psychiatric news, expert analysis, and clinical insights — subscribe today to support your practice and your patients.